Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait analysis (GCTA) is a statistical method that applies a linear mixed model to estimate phenotypic variance of complex traits explained by genome-wide SNPs, including those not associated with the trait in a GWAS. We applied GCTA to 8 cohorts containing 7096 case and 19 455 control individuals of European ancestry in order to examine the missing heritability present in Parkinson's disease (PD). We meta-analyzed our initial results to produce robust heritability estimates for PD types across cohorts. Our results identify 27% (95% CI 17-38, P = 8.08E - 08) phenotypic variance associated with all types of PD, 15% (95% CI -0.2 to 33, P = 0.09) phenotypic variance associated with early-onset PD and 31% (95% CI 17-44, P = 1.34E - 05) phenotypic variance associated with late-onset PD. This is a substantial increase from the genetic variance identified by top GWAS hits alone (between 3 and 5%) and indicates there are substantially more risk loci to be identified. Our results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 1×
“All analyses were adjusted for eigenvectors 1–20 from principal component analyses to account for possible confounding by population substructure within each cohort (22,43).”
MethodFinding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
GCTA: a tool for genome-wide complex trait analysis
Yang, J., Lee, S. H., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.011 · Cited by 8,279 · cited 15×
“It was necessary to employ more stringent quality control that what is generally acceptable for GWASs because systematic differences between cases and controls could be picked up as genetic variance (3).”
BackgroundMethodInfluentialThe combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Common SNPs explain a large proportion of the heritability for human height
Yang, J., Benyamin, B., McEvoy, B. P., Gordon, S., Henders, A. K., Nyholt, D. R., Madden, P. A., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2010) · Nature Genetics · doi:10.1038/ng.608 · Cited by 4,446 · cited 2×
“case population and to control for ascertainment, we used GCTA to transform the explained variance estimate from the observed scale (V(1)/Vp) to the underlying scale (V(1)/ Vp_L).”
Methodα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationMulticenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Self-citationMaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes
Li, Y., Willer, C. J., Ding, J., Scheet, P., & Abecasis, G. R. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20533 · Cited by 1,843 · cited 5×
“A quality threshold of a minimum 0.30 squared correlation between proximal, experimental and imputed genotypes was applied, indicated by the R 2 metric from MACH (41,42).”
MethodInfluential
Research works printed but not linked: 1
- 2011, 8, e1002548
Cited by
Items 101–197 of 197
An exome study of Parkinson’s disease in Sardinia, a Mediterranean genetic isolate
Quadri, M., Yang, X., Cossu, G., Olgiati, S., Saddi, V., Breedveld, G. J., Ouyang, L., Hu, J., Xu, N., Graafland, J., et al. (2014) · Neurogenetics · doi:10.1007/s10048-014-0425-x · Cited by 22
M endelian R andomization — the K ey to U nderstanding A spects of P arkinson's D isease C ausation?
Noyce, A. J., & Nalls, M. A. (2015) · Movement Disorders · doi:10.1002/mds.26492 · Cited by 22
“Conservative heritability estimates attributable to common genetic risk in PD are approximately 30%, even in sample series with only limited family history.(8) The monogenic forms of PD, identified through candidate gene studies, are individually sufficient to cause PD, but account for a small proportion of PD caseloa…”
BackgroundSelf-citationZhong, K., Zhu, G., Jing, X., Hendriks, E., Drop, S. L. S., Ikram, M. A., Gordon, S. D., Zeng, C., Uitterlinden, A. G., Martin, N. G., et al. (2017) · Human Genetics · doi:10.1007/s00439-017-1842-3 · Cited by 23
Kochmanski, J. J., Virani, M., Kuhn, N. C., Boyd, S., Becker, K., Adams, M., & Bernstein, A. I. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae091 · Cited by 21
Jewett, M. A. S., Jiménez-Ferrer, I., & Swanberg, M. (2017) · Brain Sciences · doi:10.3390/brainsci7070073 · Cited by 20
“, unknown genetic risk factors, in PD [6].”
BackgroundAssessment of Parkinson's disease risk loci in Greece
Kara, E., Xiromerisiou, G., Spanaki, C., Bozi, M., Koutsis, G., Πάνας, Μ., Dardiotis, E., Ralli, S., Brás, J., Letson, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.011 · Cited by 19
Self-citationSNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese
Cheng, L., Wang, L., Li, N., Yu, W.-J., Sun, X., Li, J., Zhou, D., & Peng, R. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.07.032 · Cited by 19
RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease
Nkiliza, A., Mutez, E., Simonin, C., Leprêtre, F., Duflot, A., Figeac, M., Villenet, C., Semaille, P., Comptdaer, T., Genet, A., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.014 · Cited by 20
Mancini, A., Mazzocchetti, P., Sciaccaluga, M., Megaro, A., Bellingacci, L., Beccano-Kelly, D. A., Filippo, M. D., Tozzi, A., & Calabresi, P. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00158 · Cited by 19
Fbxo7 and Pink1 play a reciprocal role in regulating their protein levels
Huang, T., Fang, L., He, R., Weng, H., Chen, X., Ye, Q., & Qu, D. (2020) · Aging · doi:10.18632/aging.202236 · Cited by 19
Establishing the role of rare coding variants in known Parkinson's disease risk loci
Jansen, I. E., Gibbs, J. R., Nalls, M. A., Price, T. R., Lubbe, S. J., van Rooij, J., Uitterlinden, A. G., Kraaij, R., Williams, N. M., Brice, A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.009 · Cited by 18
Self-citationLobón, I., Solís-Moruno, M., Juan, D., Muhaisen, A., Abascal, F., Esteller-Cucala, P., García-Pérez, R., Martí, M. J., TOLOSA, E. S., Ávila, J., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.851039 · Cited by 19
Lang, W., Wang, J., Ma, X., Zhang, N., Li, H., Cui, P., & Hao, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00297 · Cited by 17
Genome-wide estimates of heritability and genetic correlations in essential tremor
Díez-Fairén, M., Bandrés‐Ciga, S., Houle, G., Nalls, M. A., Girard, S., Dion, P. A., Blauwendraat, C., Singleton, A., Rouleau, G. A., & Pástor, P. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.05.002 · Cited by 17
Self-citationRisk prediction for complex diseases: application to Parkinson disease
Hall, T. O., Wan, J. Y., Mata, I. F., Kerr, K. F., Snapinn, K. W., Samii, A., Roberts, J. W., Agarwal, P., Zabetian, C. P., & Edwards, K. L. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.109 · Cited by 16
Molparia, B., Schrader, B. N., Cohen, E., Wagner, J. L., Gupta, S. R., Gould, S., Hwynn, N., Spencer, E. G., & Torkamani, A. (2018) · PeerJ · doi:10.7717/peerj.5308 · Cited by 15
Genetic heterogeneity of early onset Parkinson disease: The dilemma of clinico-genetic correlation
Rajan, R., Holla, V. V., Kamble, N. L., Yadav, R., & Pal, P. K. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107146 · Cited by 15
Heritability Enrichment of Immunoglobulin G N-Glycosylation in Specific Tissues
Li, X., Wang, H., Zhu, Y.-H., Cao, W., Song, M., Wang, Y., Hou, H., Lang, M., Guo, X., Tan, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741705 · Cited by 19
Structural genomic variations and Parkinson's disease
Bandrés‐Ciga, S., Ruz, C., Barrero, F. J., Sevilla, F. E., Pelegrina, J., Vives, F., & Durán, R. (2017) · Minerva Medica · doi:10.23736/s0026-4806.17.05246-6 · Cited by 15
Deciphering the Genetic Architecture of Parkinson’s Disease in IndiaPreprint
Kishore, A., Sreelatha, A. A. K., Tenghe, A., Borgohain, R., Puthanveedu, D. K., Rajan, R., Urulangodi, M., Gonzalez-Ricardo, L.-G., Pal, P. K., Kandadai, R. M., et al. (2025) · medRxiv · doi:10.1101/2025.02.17.25322132 · Cited by 16
Self-citationModi, P., Ayajuddin, M., Phom, L., Koza, Z., Das, A., Chaurasia, R., Samadder, S., Achumi, B., ., M., Pukhrambam, R. S., et al. (2016) · InTech eBooks · doi:10.5772/63767 · Cited by 15
Mo, M., Huang, W. Y., Sun, C., Zhang, L., Cen, L., Xiao, Y., Li, G.-F., Yang, X., Qu, S., & Xu, P. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.180513 · Cited by 16
SEPT14 Is Associated with a Reduced Risk for Parkinson’s Disease and Expressed in Human Brain
Rozenkrantz, L., Gan‐Or, Z., Gana‐Weisz, M., Mirelman, A., Giladi, N., Bar‐Shira, A., & Orr‐Urtreger, A. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0738-3 · Cited by 14
Genetic risk of Parkinson’s disease in the general population
Darweesh, S. K. L., Verlinden, V. J. A., Adams, H. H. H., Uitterlinden, A. G., Hofman, A., Stricker, B. H., van Duijn, C. M., Koudstaal, P. J., & Ikram, M. A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.030 · Cited by 13
Common SNCA Genetic Variants and Parkinson’s Disease Risk: A Systematic Review and Meta-Analysis
Mohammadi, R., Shirazi, M., Sadatmadani, S. F., Long, M. Z. Y. C., Singh, C. L., Tan, J. Y., Deng, X., Fard, S. M. H., Ng, S. Y., Ng, A. S. L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136001 · Cited by 13
“As common variants explain only ~27% of PD heritability [17], polygenic models, functional studies, and longitudinal cohorts are needed to clarify variant effects on disease onset and progression.”
Li, W., Fan, D., Shen, Y., Zhou, F., Chen, Y., Wang, Y., Yang, H., Mei, J., Li, L., Xu, Z.-Q., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00066-2 · Cited by 13
“However, none of them could completely explain all of the symptoms or the specific pathogenesis of PD (Keller et al. 2013; Lorraine and Kalia 2015; Nalls et al. 2011).”
BackgroundCHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking
Bar‐Shira, A., Gana‐Weisz, M., Gan‐Or, Z., Giladi, E., Giladi, N., & Orr‐Urtreger, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.014 · Cited by 13
Damena, D., & Chimusa, E. R. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz258 · Cited by 14
Parkinson’s disease-associated alterations in DNA methylation and hydroxymethylation in human brain
Choza, J., Virani, M., Kuhn, N. C., Adams, M., Kochmanski, J. J., & Bernstein, A. I. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01209-3 · Cited by 15
“An estimated 5 – 10% of Parkinson ’ s disease (PD) cases are familial and causedbymonogenicallyinheritedmutations,whiletheremaining~90%of sporadiccases(sPD)arelikelyduetoacomplexinteractionbetweenage, genes,andenvironmentalfactors 1 – 3 .”
Liu, F.-C., Lin, H.-T., Kuo, C., Hsieh, M.-Y., See, L., & Yu, H. (2018) · Clinical Epidemiology · doi:10.2147/clep.s164330 · Cited by 14
Baroli, B. M., Loi, E., Solari, P., Kasture, A. S., Moi, L., Muroni, P., Kasture, S. B., Setzu, M. D., Liscia, A. M., & Zavattari, P. (2019) · The FASEB Journal · doi:10.1096/fj.201901010 · Cited by 11
Singh, R. S. (2021) · Journal of Molecular Evolution · doi:10.1007/s00239-021-10023-3 · Cited by 11
Parkinson’s disease GWAS-linked Park16 carriers show greater motor progression
Deng, X., Xiao, B., Allen, J. C., Ng, E., Foo, J. N., Lo, Y., Tan, L. C. S., & Tan, E. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105661 · Cited by 11
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease
Gionco, J. T., & Bernstein, A. I. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230457 · Cited by 12
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Basso, V., Döbrössy, M. D., Thompson, L. H., Kirik, D., Fuller, H. R., & Gates, M. A. (2024) · Biology · doi:10.3390/biology13090690 · Cited by 12
Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions
Partnership, I. A. H. P., Li, X., Price, M. A., He, D., Kamali, A., Karita, E., Lakhi, S., Sanders, E. J., Anzala, O. A., Amornkul, P. N., et al. (2014) · Human Genetics · doi:10.1007/s00439-014-1465-x · Cited by 11
Genome-Wide Estimates of Heritability for Social Demographic Outcomes
Domingue, B. W., Wedow, R., Conley, D., McQueen, M. B., Hoffmann, T. J., & Boardman, J. D. (2016) · Biodemography and Social Biology · doi:10.1080/19485565.2015.1068106 · Cited by 13
Gaare, J. J., Nido, G. S., Dölle, C., Sztromwasser, P., Alves, G. W., Tysnes, O., Haugarvoll, K., & Tzoulis, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239824 · Cited by 11
Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study
Zhao, Y., & Taliun, S. A. G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.940118 · Cited by 9
Proceedings: Cell Therapies for Parkinson's Disease From Discovery to Clinic
Canet-Aviles, R., Lomax, G. P., Feigal, E. G., & Priest, C. A. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0146 · Cited by 9
Synuclein and Parkinson’s Disease: An Update
Jellinger, K. A. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737357-00175 · Cited by 9
Lou, F., Li, M., Liu, N., Li, X., Ren, Y., & Luo, X. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1526796 · Cited by 10
Heritability of pulmonary function estimated from genome-wide SNPs in healthy Japanese adults
Yamada, H., Yatagai, Y., Masuko, H., Sakamoto, T., Iijima, H., Naito, T., Noguchi, E., Hirota, T., Tamari, M., & Hizawa, N. (2014) · Respiratory Investigation · doi:10.1016/j.resinv.2014.10.004 · Cited by 9
Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia
Vergouw, L. J. M., Geut, H., Breedveld, G. J., Kuipers, D. J. S., Quadri, M., Bank, N. B., Rozemüller, A. J. M., Swieten, J. C. V., de Jong, F. J., van de Berg, W. D. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200318 · Cited by 9
Simón‐Sánchez, J., Heutink, P., & Gasser, T. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.008 · Cited by 8
Self-citationFunctional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease
Finkbeiner, S. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105088 · Cited by 8
Etiology and pathogenesis of Parkinson disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00005-6 · Cited by 9
Functional genomics elucidates regulatory mechanisms of Parkinson’s disease-associated variants
Chen, R., Liu, J., Li, S., Li, X., Huo, Y., Yao, Y., Xiao, X., Li, M., & Luo, X. (2022) · BMC Medicine · doi:10.1186/s12916-022-02264-w · Cited by 8
Cisterna‐García, A., Bustos, B. I., Bandrés‐Ciga, S., Leal, T. P., Sarihan, E. I., Jok, C., Blauwendraat, C., Nalls, M. A., Krainc, D., Singleton, A., et al. (2024) · Brain · doi:10.1093/brain/awae398 · Cited by 8
Self-citationIntrons control stochastic allele expression bias
Sands, B., Yun, S. R., & Mendenhall, A. (2021) · Nature Communications · doi:10.1038/s41467-021-26798-4 · Cited by 8
Lin, Y.-C., Hsieh, A., Hsiao, C.-L., Wu, S.-J., Wang, H., Lian, I., & Fann, C. S. J. (2014) · Journal of Biomedical Science · doi:10.1186/s12929-014-0088-9 · Cited by 8
Eubanks, E., VanderSleen, K., Mody, J., Patel, N., Sacks, B., Darestanifarahani, M., Wang, J., Elliott, J., Jaber, N. S., Akçimen, F., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115636 · Cited by 7
Self-citationTargeted copy number variant identification across the neurodegenerative disease spectrum
Dilliott, A. A., Zhang, K. K., Wang, J., Abrahão, A., Binns, M. A., Black, S. E., BORRIE, M. J., Dowlatshahi, D. D., Finger, E. C., Fischer, C. E., et al. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1986 · Cited by 7
“…E Y W O R D S cerebrovascular disease, copy number variants, neurodegenerative disease, next- generation sequencing reach these estimates, leaving a large amount of missing heritability (Cacace et al., 2016; Hagenaars et al., 2018; Keller et al., 2012; Mejzini et al., 2019).”
BackgroundHu, J. S., Waters, C., Spiegelman, D., Fon, E. A., Yu, E., Asayesh, F., Krohn, L., Saini, P., Alcalay, R. N., Hassin‐Baer, S., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.012 · Cited by 7
Parkinson’s Disease: Basic Pathomechanisms and a Clinical Overview
Noyce, A. J., & Bandopadhyay, R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_3 · Cited by 7
Parkinson’s Disease: Insights from Drosophila Model
Ayajuddin, M., Das, A., Phom, L., Modi, P., Chaurasia, R., Koza, Z., Thepa, A., Jamir, N., Singh, P. R., Longkumer, S., et al. (2018) · InTech eBooks · doi:10.5772/intechopen.72021 · Cited by 8
“Large-scale genome and exome sequencing in conjunction with denser genotyping in large cohorts may help to identify the loci that contribute to the “missing heritability” previously unnoticed by earlier generation technologies [151].”
Simón‐Sánchez, J., & Gasser, T. (2015) · Neurology · doi:10.1212/wnl.0000000000001345 · Cited by 7
“While these studies have demonstrated an unequivocal role for common variation in the etiology of PD, they only explain a fraction of the expected heritability.(4) Thus, common variants of smaller effect, as well as rare variants of moderate effects, remain to be discovered.”
BackgroundSelf-citationGenome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease RiskPreprint
Han, Y., Teeple, E. A., Shankara, S., Sadeghi, M., Zhu, C., Liu, D., FinnGen, Wang, C., Frau, F., Klinger, K. W., et al. (2020) · medRxiv · doi:10.1101/2020.10.16.20212944 · Cited by 7
“Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk Yingnan Han1*, Erin Teeple1*, Srinivas Shankara1, Mahdiar Sadeghi1, Cheng Zhu1, Dongyu Liu1, FinnGen2, Clarence Wang1, Francesca Frau3, Katherine W. Klinger1, Stephen L. Madden1, Deepak Rajpal1, S. Pablo Sardi3, Dinesh Kumar1#…”
BackgroundInfluentialManfredi, J. M., Jacob, S. I., & Norton, E. M. (2023) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.22.11.0485 · Cited by 6
Genetics of Equine Endocrine and Metabolic Disease
Norton, E. M., & McCue, M. E. (2020) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2020.03.011 · Cited by 5
Association between NOTCH3 gene and Parkinson’s disease based on whole-exome sequencing
Zeng, Q., Pan, H., Zhao, Y., Wang, Y., Xu, Q., Tan, J., Yan, X., Li, J., Tang, B., & Guo, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.995330 · Cited by 5
Genetics of Parkinson’s Disease
Hernandez, D. G., & Singleton, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_2 · Cited by 5
Self-citationDuarte-Zambrano, F., Alfonso-Cedeño, D. F., Barrero, J. A., Rodríguez-Vanegas, L. A., Moreno-Cárdenas, V., Olarte-Díaz, A., Arboleda, G., & Arboleda, H. (2025) · Neurogenetics · doi:10.1007/s10048-025-00817-8 · Cited by 6
“However, more than half of this polygenic variance remains unaccounted for in current genome-wide association studies [5].”
Contribution of Genetic Epidemiology to Our Understanding of Psychiatric Disorders
Merikangas, K. R., & Merikangas, A. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00002-0 · Cited by 4
Bioinformatics in the Identification of Novel Targets and Pathways in Neurodegenerative Diseases
Paananen, J. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0115-8 · Cited by 5
Genetics of REM Sleep Behavior Disorder
Gan‐Or, Z., & Rouleau, G. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90152-7_41 · Cited by 6
Role of LRP10 in Parkinson's disease in a Taiwanese cohort
Liao, T.-W., Wang, C., Chung, W., Su, S., Chin, S.-H., Fung, H., & Wu, Y. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.06.026 · Cited by 3
Reduced penetrance of Parkinson’s disease models
Morais, V. A., & Vos, M. H. (2022) · Medizinische Genetik · doi:10.1515/medgen-2022-2138 · Cited by 4
“Genetic variation is estimated to contribute approximately 25 % to the overall risk of developing PD [6, 7].”
BackgroundPascual, A., Moulka, T., de Fàbregues, O., Repossi, R., Ruiz, P., Ortolano, S., Lucca, M. D., Vela, L., Alves-Villar, M., Frías, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199454 · Cited by 2
Gong, Y., Paul, K. C., Rosario, I. D., Zhang, K., Cockburn, M. G., Thompson, L. W., Keener, A. M., Bronstein, J. M., & Ritz, B. R. (2026) · Environmental Research Health · doi:10.1088/2752-5309/ae4645 · Cited by 2
“Heritability estimates suggest that genetic variants account for approximately 10% to 30% of the variation in PD risk, leaving a substantial portion for environmental influences in addition to aging and stochastic processes [4–6].”
Templeton, A. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-386025-5.00008-7 · Cited by 1
Gruschus, J. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85707-9.00012-5 · Cited by 1
Brewczyński, P. Z. (2014) · Medical Science Monitor · doi:10.12659/msm.890506 · Cited by 1
Billingsley, K. J. (2020) · University of Liverpool · doi:10.17638/03056036 · Cited by 1
Pathogenesis, prevention and treatment of peripheral artery disease
Brodziak, A. (2014) · Annales Academiae Medicae Silesiensis · Cited by 1
Exome Variant Mining in Familial Parkinson Disease: Will Replication Find the Gold?
Toft, M., & Ross, O. A. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3536
Disner, S. G. (2015) · Texas ScholarWorks (Texas Digital Library) · doi:10.15781/t2k33h
Zebrafish as a translational model of Parkinson's disease : a study of microRNAs
Trollope, L. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Interpretation and improvement of the current genetic epidemiology methodology for schizophrenia
Rammos, A. (2018) · Arrow@dit (Dublin Institute of Technology)
Billingsley, K. J., Barbosa, I. A., Bandrés‐Ciga, S., Quinn, J. P., Bubb, V. J., Deshpande, C., Botía, J. A., Reynolds, R. H., Zhang, D., Simpson, M. A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/475111
Self-citationDetection of somatic variants from genomic data and their role in neurodegenerative diseases
García, I. L. (2019) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Family neurologic and psychiatric history and the risk of autism spectrum disorder
Xie, S. L., & Lee, B. K. (2018) · iDEA - Drexel University Institutional Repository · doi:10.17918/ndtz-jz80
Renton, A. E., & Goate, A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0051
Comino, A., Antolín‐Vallespín, M., López-Benito, A., Muñoz, G., del Castillo, F. J., Vela, L., Martínez‐Castrillo, J. C., & Sánchez‐Capelo, A. (2022) · medRxiv · doi:10.1101/2022.07.09.22277447
Sharma, A., & Kaur, G. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040197123010009
Genetics of Alzheimer’s Disease, Parkinson’s Disease, and Lewy Body Dementia
Renton, A. E., Fulton‐Howard, B., Andrews, S. J., Marcora, E. M., & Goate, A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0053
From cigarettes to compulsions: a longitudinal study in de novo Parkinson's disease
Massara, M., Vedovelli, L., Masina, F., Edelstyn, N., Bisiacchi, P. S., & Rosa, E. D. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1708535
“In these models, smoking-related neuroadaptations lead to pathological symptoms only in a susceptible PD context (Keller et al., 2012; Wirdefeldt et al., 2011).”
InfluentialThe role of alternative splicing and long non-coding RNAs in parkinson’s disease
Kavanagh, T. (2018) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/3687
The Genetic Landscape of Neurodegenerative and Cerebrovascular Disease Phenotypes.
Dilliott, A. A. (2021) · Scholarship@Western (Western University)
Nannoni, M. (n.d.) · BOA (University of Milano-Bicocca)
Graham, O. (2024) · Otago University Research Archive (University of Otago)
Translating Parkinson disease genetics into clinical benefit
Avenali, M., Imarisio, A., & Valente, E. M. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01283-y
Metadata
- Authors
- Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., Schulte, C., Moskvina, V., Durr, A., Holmans, P., Kilarski, L. L., Guerreiro, R., Hernandez, D. G., Brice, A., Ylikotila, P., Stefansson, H., Majamaa, K., Morris, H. R., Williams, N., Gasser, T., Heutink, P., Wood, N. W., Hardy, J., Martinez, M., Singleton, A. B., Nalls, M. A., & for the International Parkinson's Disease Genomics Consortium (IPDGC) and The Wellcome Trust Case Control Consortium 2 (WTCCC2)
- Affiliations
- National Institutes of Health (US)
- Université Toulouse III - Paul Sabatier (FR)
- deCODE Genetics (Iceland) (IS)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- German Center for Neurodegenerative Diseases (DE)
- Cardiff University (GB)
- UCL Queen Square Institute of Neurology (GB)
- Centre National de la Recherche Scientifique (FR)
- University of Turku (FI)
- University of Oulu (FI)
- Corresponding author
- Nalls, M. A.
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-13
- Volume
- 21
- Issue
- 22
- Pages
- 4996-5009
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC3576713
- OpenAlex
- W2132869184
- Cited by
- 190
- References
- 51
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 18 · 2021: 11 · 2020: 13 · 2019: 18 · 2018: 22 · 2017: 17 · 2016: 21 · 2015: 18 · 2014: 18 · 2013: 9 · 2012: 2
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Research Portal (Queen's University Belfast) (publishedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- CLOK (University of Central Lancashire) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Wellcome Trust (083948/Z/07/Z, 090532, 089698, WT089698/Z/09/Z)
- National Institute for Health and Care Research (NF-SI-0507-10376)
- Parkinson's UK (G0909, J-0901, G-1107, J‐0804)
- National Institutes of Health (1z01es101986-03, UL1TR000448, Z01-ES101986, Z01-AG000949)
- Medical Research Council (MC_G1000735, MC_PC_09003, MC_G0901330)
- National Institute on Aging (Z01AG000949)
- National Institute of Neurological Disorders and Stroke (P30NS057105, NS057105, R01NS041509, R01NS075321)
- National Institute of Environmental Health Sciences (Z01-ES 101986)
- National Center for Research Resources (RR-024992, UL1RR024992)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and phenotypic traits in livestock
- Keywords
- Parkinson's disease, missing heritability, GCTA, heritability, early-onset Parkinson's disease, late-onset Parkinson's disease, genetic susceptibility loci
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Parkinson Disease, Genetic Variation, Quantitative Trait, Heritable, Genetic Predisposition to Disease, Multifactorial Inheritance, White People, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.